GLP-1 Microdosing for Preventive Health Glucagon-like peptide-1s (GLP-1s) are widely recognized for their role in diabetes management and weight loss
A review published in Trends in Cardiovascular Medicine found that monthly lifestyle counseling visits improved adherence and weight loss outcomes at 68 weeks.10 Interestingly, individuals who followed a more intensive, nonpharmacologic plan (including meal replacements and behavioral therapy) achieved similar weight loss results at 68 weeks compared with those using injectables.10 These findings further highlight the value of consistent, structured nutrition counseling in promoting sustainable weight management
in addition to its crucial role in maintaining genomic stability and regulating inflammation, SIRT6 also directly deacetylates NAMPT, enhancing its activity and promoting NAD + synthesis via the salvage pathway
As patients experience significant appetite suppression and reduced food intake, they may experience transient symptoms including fatigue, headache, and body discomfort
There are no clinical studies on the efficacy, safety, or dosing of GLP-1 patches, but they will likely follow the titrating dosing method, similar to GLP-1 injections